Fundraising Fox

Steve Liapis

Investor

Managing Director at Northpond Ventures · Board director at Merge Bio Therapeutics

Boston, Massachusetts, United States

Find your path to Steve

362 people in our graph share verified history with Steve — schools, employers, funds. One of them is your warm intro.

Karthik ArdhanareeswaranunlockedSteve: together at Yale University (2011–2012)
×3Steve: together at Harvard University
×2Steve: together at Yale University
×6Steve: together at Northpond Ventures

About

Steve Liapis is Vice President at Northpond Ventures, where his work spans technology and operations. His experience includes cybersecurity modernization, infrastructure strategy, multi-office operations, vendor governance, and portfolio enablement across venture capital and enterprise environments.

Board director at Merge Bio Therapeutics

Intro paths

→

In turn, Steve can intro founders to Merge Bio Therapeutics's investors below.

Merge Bio Therapeutics's investors · 1

Northpond VenturesBethesda · $100K – $5M checks · since 2025

Experience

  1. Northpond VenturesManaging Directorcurrent2024 — present
  2. Northpond VenturesDirector2023 — 2024Cambridge, Massachusetts, United States
  3. Northpond VenturesPrincipal2021 — 2023Cambridge, Massachusetts, United States
  4. Weaver BiosciencesBoard Membercurrent2024 — present
  5. Aro BiotherapeuticsBoard Membercurrent2023 — present
  6. Totus MedicinesBoard Membercurrent2022 — present
  7. Incendia TherapeuticsBoard Membercurrent2022 — present
  8. Opna BioBoard Membercurrent2022 — present
  9. Stratus TherapeuticsBoard Member2023 — 2025
  10. Kyverna TherapeuticsBoard Member2022 — 2025
  11. SanofiDirector of Oncology Portfolio Strategy2020 — 2021Cambridge, Massachusetts, United States
  12. Arbor BiotechnologiesHead of Strategy & Director of Corporate Development2019 — 2020Cambridge, Massachusetts, United States
  13. L.E.K. ConsultingLife Sciences Strategy Consultant (Engagement Manager)2016 — 2019Greater Boston Area
  14. Harvard UniversityPh.D. Candidate2012 — 2016Cambridge, MA

Skills & more

Molecular Biology14Biochemistry11Cell Biology8Cell Culture2Genomics3Science5PCR3Life Sciences4Genetics2Strategy1

Languages English · Greek · Spanish

From Steve's professional profile.

Deals · 1

Merge Bio TherapeuticsBoard seat

via Northpond Ventures · filed Sep 2025 · $15M raise

Attribution from SEC filings, press coverage, and firm rosters.

Colleagues at Northpond Ventures

Alexis Fleming
Manager, Portfolio Operations & Administration at Northpond Ventures
Andrea Jackson
Partner at Northpond Ventures
Andrew Lee
Managing Director at Northpond Ventures
Anirvan Chowdhury
Director at Qualcomm Ventures
Anjali Jagannath
Vice President, Finance at Northpond Ventures
Ashley Cowher
Senior Executive Assistant at Northpond Ventures
Ben Hartheimer
Senior Associate, Portfolio Operations at Northpond Ventures
Catherine Gamble
Manager, Corporate Finance at Northpond Ventures

Frequently asked questions

Who is Steve Liapis?
Steve Liapis is Vice President at Northpond Ventures, where his work spans technology and operations. His experience includes cybersecurity modernization, infrastructure strategy, multi-office operations, vendor governance, and portfolio enablement across venture capital and enterprise environments.
Where does Steve Liapis work?
Steve Liapis is Managing Director at Northpond Ventures and Board director at Merge Bio Therapeutics.
What boards does Steve Liapis sit on?
Steve Liapis holds tracked board seats at Merge Bio Therapeutics.
Where did Steve Liapis go to school?
Steve Liapis studied at Harvard University (Doctor of Philosophy (Ph.D.), Molecular Biology); Yale University (Master of Science (M.Sc.), Plant Physiology and Plant Genetics).

Same school

Also attended Harvard University2,000

Ron ConwayFounder of SV AngelAlfred LinPartner at Sequoia CapitalChris DixonFounder & Managing Partner of a16z crypto at Andreessen HorowitzSarah TavelVenture Partner at BenchmarkDanny RimerPartner at Index VenturesLaela SturdyManaging Partner at CapitalG

+ 1,994 more

Also attended Yale University1,080

Ann Miura-KoCo-founding Partner at FloodgateDavid SzeAdvisory Partner at GreylockMichael SeibelPartner Emeritus at Y CombinatorBen SilbermannCo-founder of PinterestZheela QaiserInvestor at Index VenturesAnthony PhilippakisInvestor at GV (Google Ventures)

+ 1,074 more

Shared employers

Also worked at Weaver Biosciences2

Aleks Radovic-MorenoPartner at Longwood FundLizzie NgoPrincipal at Longwood Fund

Also worked at Stratus Therapeutics3

David KirskeExecutive Officer at X4 PharmaAdam CraigExecutive Officer, Director at X4 PharmaRobert DoebeleChief Medical Officer at Boundless Bio

Also worked at Kyverna Therapeutics5

Chris WeyrerPrincipal at Vida VenturesJonathan HostensInvestor at Insight PartnersPeter MaagExecutive Officer, Director at CareDxDominic BorieChief Medical Officer and Head of Research and Development at Cue BiopharmaWarner BiddleChief Executive Officer at Kyverna Therapeutics

Also worked at Sanofi249

Walter OlesiakOperating Partner at Remiges Ventures, Inc.Christine AylwardFounder & Managing Partner at Magnetic VenturesAlan WaltsVenture Partner at Advent Life SciencesSun AltbachSenior Scientific Advisor at BOLD LongevityMatt VineSenior Associate at RRE VenturesRamy RiadPresident, Plasma-Derived Therapies Business Unit at Takeda Ventures

+ 243 more